An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com

Inclusion Criteria:

- Diagnosis of JIA (any subtype)

- Age < 18 years at the time of enrollment unless currently or previously enrolled in an
abatacept clinical trial and received abatacept

- Receiving Abatacept at the time of enrollment as per treating physician's decision or
received abatacept in a clinical trial

- Parent or legally acceptable representative willing to participate in the study and
sign the informed consent

Exclusion Criteria:

- Pregnant or nursing female at the time of enrollment

- Prior malignancies if the patient has not been malignancy free for at least 5 years.

- Any serious acute or chronic medical condition other than JIA, including chronic
infection, which would compromise the patient's ability to participate in the study

- Known poor compliance with clinic visits (based on physician judgment)